Xiao Juan, Zou Ping, Liu Zhongwen, Hu Zhongbo, Liu Lingbo
Institute of Hematology, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022.
J Huazhong Univ Sci Technolog Med Sci. 2002;22(3):197-9. doi: 10.1007/BF02828178.
To assess the value of CD34+ cells transferred exogenous Fas ligand (FasL) in inducing apoptosis of human leukemic cells, the CD34+ cells transfected with FasL or without, pretreated with mitomycin C, was mixed with leukemic cell line U937 cells in presence or absence of daunorubicin (DNR) or cytosine arabinoside (Ara-C). After 18 h, apoptosis of cells was detected by FCM and TUNEL. Induced for 18 h by CD34+ cells transfected with FasL or without, the ratio of apoptosis of U937 cells was (5.0 +/- 1.3)%, (10.8 +/- 0.6)% (P < 0.01), respectively. Induced by FasL+ CD34+ + DNR, FasL+ CD34+ + Ara-C, the ratio was (13.4 +/- 1.0)% (P < 0.05), (17.9 +/- 1.3)% (P < 0.01), respectively. The result demonstrated that CD34+ cells transfected with exogenous FasL could induce apoptosis of human leukemic cells and showed a cytotoxic synergistic effect when used in combination with chemotherapeutic drugs, suggesting that it was possible to develop a new method in treatment of leukemia.
为评估转染外源性Fas配体(FasL)的CD34+细胞在诱导人白血病细胞凋亡中的价值,将转染或未转染FasL且经丝裂霉素C预处理的CD34+细胞,在有或无柔红霉素(DNR)或阿糖胞苷(Ara-C)存在的情况下,与白血病细胞系U937细胞混合。18小时后,通过流式细胞术(FCM)和末端脱氧核苷酸转移酶介导的缺口末端标记法(TUNEL)检测细胞凋亡情况。转染或未转染FasL的CD34+细胞诱导18小时后,U937细胞的凋亡率分别为(5.0±1.3)%、(10.8±0.6)%(P<0.01)。FasL+CD34++DNR、FasL+CD34++Ara-C诱导后,凋亡率分别为(13.4±1.0)%(P<0.05)、(17.9±1.3)%(P<0.01)。结果表明,转染外源性FasL的CD34+细胞可诱导人白血病细胞凋亡,且与化疗药物联合使用时显示出细胞毒性协同效应,提示有可能开发出一种治疗白血病的新方法。